AH
Anantpur Harish Murty
About Anantpur Harish Murty
Data last updated:
Anantpur Harish Murty is a Director at Numida Biocare Private Limited (since 2020) and Director at Nulinks Pharma Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Numida Biocare Private Limited at ₹9.27 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jul 2020 | 2020 | ₹9.27 Cr (FY 2025) | Active | |
| Director | 29 Sep 2025 | 2025 | Active |
Board colleagues of Anantpur Harish Murty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Altafmiya Jahidmiya Malek | 08789645 | Numida Biocare Private Limited | Managing Director |
| Parveen Altafmiya Malek | 08789647 | Numida Biocare Private Limited | Director |
| Sudha Murty | 11321390 | Nulinks Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anantpur Harish Murty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anantpur Harish Murty
Anantpur Harish Murty currently holds 2 directorships: Numida Biocare Private Limited (Director, since 11 Jul 2020, revenue ₹9.27 Cr (FY 2025)); Nulinks Pharma Private Limited (Director, since 29 Sep 2025).
Anantpur Harish Murty was first appointed on 11 Jul 2020 as Director at Numida Biocare Private Limited. The most recent appointment on record is 29 Sep 2025 at Nulinks Pharma Private Limited.
The current boards of Anantpur Harish Murty's companies include Altafmiya Jahidmiya Malek (Numida Biocare Private Limited), Parveen Altafmiya Malek (Numida Biocare Private Limited), Sudha Murty (Nulinks Pharma Private Limited).